|
Isokinetic Muscle Endurance Indices for the CoQ10 and Placebo (CON) groups. |
|||||
| Variable |
Time |
CoQ10 |
Placebo |
Significance |
|
|
|
|||||
| Peak Torque EXT (N/m) |
Baseline |
132 ± 42 |
110 ± 38 |
Group |
0.181 |
| Day 0 |
127 ± 37 |
110 ± 34 |
Time |
0.265 |
|
| Day 14 |
132 ± 34 |
107 ± 35 |
G × T |
0.495 |
|
| Peak Torque FLX (N/m) |
Baseline |
72 ± 28 |
65 ± 26 |
Group |
0.218 |
| Day 0 |
75 ± 28 |
66 ± 28 |
Time |
0.534 |
|
| Day 14 |
73 ± 24 |
65 ± 28 |
G × T |
0.488 |
|
| Total Work EXT (N/m) |
Baseline |
4047 ± 1218 |
3391 ± 992 |
Group |
0.826 |
| Day 0 |
3955 ± 1114 |
3352 ± 936 |
Time |
0.308 |
|
| Day 14 |
4073 ± 1116 |
3242 ± 921 |
G × T |
0.442 |
|
| Total Work FLX (N/m) |
Baseline |
2213 ± 847 |
1962 ± 891 |
Group |
0.127 |
| Day 0 |
2203 ± 877 |
1996 ± 963 |
Time |
0.493 |
|
| Day 14 |
2230 ± 822 |
1866 ± 839 |
G × T |
0.591 |
|
| Work Fatigue EXT (%) |
Baseline |
48 ± 15 |
41 ± 17 |
Group |
0.112 |
| Day 0 |
46 ± 14 |
37 ± 19 |
Time |
0.160 |
|
| Day 14 |
48 ± 11 |
36 ± 20 |
G × T |
0.309 |
|
| Work Fatigue FLX (%) |
Baseline |
46 ± 20 |
43 ± 29 |
Group |
0.132 |
| Day 0 |
51 ± 14 |
35 ± 30 |
Time |
0.534 |
|
| Day 14 |
51 ± 16 |
44 ± 14 |
G × T |
0.192 |
|
| AVG Power EXT (Watts) |
Baseline |
117 ± 36 |
95 ± 30 |
Group |
0.476 |
| Day 0 |
115 ± 34 |
95 ± 27 |
Time |
0.315 |
|
| Day 14 |
117 ± 33 |
95 ± 30 |
G × T |
0.351 |
|
| AVG Power FLX (Watts) |
Baseline |
61 ± 25 |
52 ± 25 |
Group |
0.106 |
| Day 0 |
62 ± 26 |
54 ± 27 |
Time |
0.334 |
|
| Day 14 |
62 ± 24 |
52 ± 26 |
G × T |
0.402 |
|
|
Data are means and ± standard deviations of mean | |||||
Cooke et al. Journal of the International Society of Sports Nutrition 2008 5:8 doi:10.1186/1550-2783-5-8 |
|||||